CVS Health Corp. sell Biotechhunter
Summary
This prediction ended on 15.07.21 with a price of €69.52. The price for CVS Health Corp. massively increased, which is bad news for the SELL prediction by Biotechhunter. Dividends of €1.25 are taken into consideration when calculating the performance. Biotechhunter has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| CVS Health Corp. | -1.797% | -1.797% | 32.286% | -17.060% |
| iShares Core DAX® | 0.191% | 4.771% | 20.559% | 64.548% |
| iShares Nasdaq 100 | -0.614% | 3.137% | 5.816% | 110.363% |
| iShares Nikkei 225® | 0.599% | 8.016% | 21.913% | 55.210% |
| iShares S&P 500 | -0.036% | 3.593% | 3.588% | 70.174% |
Comments by Biotechhunter for this prediction
In the thread CVS Health Corp. diskutieren